about
Role of F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma.Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.Functional restoration of the esophagus after peroral endoscopic myotomy for achalasia.Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis.Russell body gastritis associated with Helicobacter pylori infection: a case reportGrowth Patterns of Signet Ring Cell Carcinoma of the Stomach for Endoscopic Resection.Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.A case of more abundant and dysplastic adenomas in the interposed colon than in the native colon.Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study.Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.Proteomic analysis of CD44(+) and CD44(-) gastric cancer cells.Clinical application of self-expandable metallic stent for treatment of colorectal obstruction caused by extrinsic invasive tumors.Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs.Advanced gastric cancer showing complete remission of metastatic lymph node after chemotherapy.Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study.Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer.Risk-Stratification Model Based on Lymph Node Metastasis After Noncurative Endoscopic Resection for Early Gastric Cancer.Poorly Differentiated Carcinoma Component in Submucosal Layer Should be Considered as an Additional Criterion for Curative Endoscopic Resection of Early Gastric Cancer.Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancerTreatment outcomes of 70 cases of early esophageal carcinoma: 12 years of experienceTwo cases of low grade gastric-mucosa–associated lymphoid tissue lymphoma treated by EMRDefining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineationUpregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cellsLymphovascular invasion is an important predictor of lymph node metastasis in endoscopically resected early gastric cancersTen-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in KoreaProspective Observational Study of the Clinical Prognoses of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalisClinicopathologic Features of Submucosal Papillary Gastric Cancer Differ from Those of Other Differentiated-Type HistologiesThe Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study
P50
Q30474120-E915D8C1-52C3-46BC-B565-114FC1C2D455Q33348147-7568A4CB-59AC-43F6-A42B-E48727C1FEB1Q33719102-6304901F-4054-43F4-AE3D-4A49253F6441Q35152348-A38C14E2-D1E9-4D7C-AAAC-DEDC63B44C5BQ35470416-29381312-BA18-4974-8D09-F4F325D43337Q35770455-2A82C285-B0D7-416A-B558-02D3C7988387Q36223392-15CE3C8F-AE6B-4DE8-96C7-C25960A66433Q36292688-FC43D09D-46F8-4465-9B03-EBB4433B809FQ37065675-9DE22BAE-993F-406C-A0F1-3293D35DC76DQ38446164-E019B479-2094-456B-B94F-E45F3D8C1C1FQ38803935-27B4650F-77D7-4CAC-BA08-45ED7F43BD7CQ38969786-4BBE9B99-8B05-49A3-A334-AA78F277B842Q39324028-877FB4F5-A18C-4945-B335-4A4BAF5801F7Q40473467-8B7A52DF-6A2F-450B-B516-EE7D43B186E0Q40607884-C8A59F90-47C2-4F8E-AFF0-C17BA351EFBFQ40908062-CB7DC110-018D-4EC4-A51D-84F27CD8C75BQ42702657-60D3B6E8-AF69-460E-A7AA-C31F36FD5DBFQ47139271-A7F71CB1-FEEE-4EDB-A2BD-2ED94AD1B0A1Q47872847-38C4CE01-AEC7-47A7-B02D-35A41DCF376BQ50998429-1707DF53-5416-4A8E-950C-87D40D6A22FEQ55081438-78BDA153-0860-4E7A-BD78-67ABB51B373BQ57211942-F43A6F7B-D6EB-472D-96EF-B064AD5ADD67Q57212524-27B15BC9-C53F-4FE3-B7C0-765E93DD3FC1Q58202859-9C81EB4A-96B6-496B-BC0C-D9ED4BDCC007Q59115813-3E19DD9C-9715-42A3-A66E-D814A1CFDD8DQ61813045-085F4FCF-436A-4F5E-877F-FF59D85DC648Q83760822-330CF01A-A127-4BED-B9FF-65F8E67D95EEQ90041535-E7C642D8-BE37-453C-B538-95D0A27A2040Q90212720-28E10CE6-2DF0-434E-AA77-6517ACB3D7F2Q91965191-EE68D02F-C535-42C2-9B6B-D07FFA2E8E71Q93004305-80CC2DA5-90C2-48D5-A18A-9E837A848003
P50
description
researcher
@en
wetenschapper
@nl
name
Yongchan Lee
@en
Yongchan Lee
@nl
type
label
Yongchan Lee
@en
Yongchan Lee
@nl
prefLabel
Yongchan Lee
@en
Yongchan Lee
@nl
P106
P31
P496
0000-0001-8800-6906